These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 31142374)

  • 1. Research activity and capability in the European reference network MetabERN.
    Heard JM; Bellettato C; van Lingen C; Scarpa M;
    Orphanet J Rare Dis; 2019 May; 14(1):119. PubMed ID: 31142374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Availability, accessibility and delivery to patients of the 28 orphan medicines approved by the European Medicine Agency for hereditary metabolic diseases in the MetabERN network.
    Heard JM; Vrinten C; Schlander M; Bellettato CM; van Lingen C; Scarpa M;
    Orphanet J Rare Dis; 2020 Jan; 15(1):3. PubMed ID: 31907071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards quality, comprehensiveness and excellence. The accreditation project of the Organisation of European Cancer Institutes (OECI).
    Saghatchian M; Hummel H; Otter R; de Valeriola D; Van Harten W; Paradiso A; Koot B; Ringborg U; Tursz T;
    Tumori; 2008; 94(2):164-71. PubMed ID: 18564602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A proposal for reforming psychologists' training in France and in the European Union].
    Bouchard JP
    Encephale; 2009 Feb; 35(1):18-24. PubMed ID: 19250989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Social and medical needs of rare metabolic patients: results from a MetabERN survey.
    Sestini S; Paneghetti L; Lampe C; Betti G; Bond S; Bellettato CM; Maurizio S
    Orphanet J Rare Dis; 2021 Aug; 16(1):336. PubMed ID: 34344397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ERN BOND: The key European network leveraging diagnosis, research, and treatment for rare bone conditions.
    Casareto L; Appelman-Dijkstra NM; Brandi ML; Chapurlat R; Cormier-Daire V; Hamdy NAT; Heath KE; Horn J; Mantovani G; Mohnike K; Sousa SB; Travessa A; Wekre LL; Zillikens MC; Sangiorgi L;
    Eur J Med Genet; 2024 Apr; 68():104916. PubMed ID: 38296035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Conceptual assumptions to create a system for preparation of healthcare human resources in Ukraine].
    Грузєва ТС; Пельо ІМ; Сміянов ВА; Галієнко ЛІ
    Wiad Lek; 2016; 69(6):719-725. PubMed ID: 28214802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complementary and alternative medicine for cancer patients: results of the EPAAC survey on integrative oncology centres in Europe.
    Rossi E; Vita A; Baccetti S; Di Stefano M; Voller F; Zanobini A
    Support Care Cancer; 2015 Jun; 23(6):1795-806. PubMed ID: 25471177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A descriptive survey study of violence management and priorities among psychiatric staff in mental health services, across seventeen european countries.
    Cowman S; Björkdahl A; Clarke E; Gethin G; Maguire J;
    BMC Health Serv Res; 2017 Jan; 17(1):59. PubMed ID: 28103871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges in Transition From Childhood to Adulthood Care in Rare Metabolic Diseases: Results From the First Multi-Center European Survey.
    Stepien KM; Kieć-Wilk B; Lampe C; Tangeraas T; Cefalo G; Belmatoug N; Francisco R; Del Toro M; Wagner L; Lauridsen AG; Sestini S; Weinhold N; Hahn A; Montanari C; Rovelli V; Bellettato CM; Paneghetti L; van Lingen C; Scarpa M
    Front Med (Lausanne); 2021; 8():652358. PubMed ID: 33738294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A survey of perceived problems in orthodontic education in 23 European countries.
    Sieminska-Piekarczyk B; Adamidis JP; Eaton KA; McDonald JP; Seeholzer H
    J Orthod; 2000 Dec; 27(4):343-8. PubMed ID: 11099579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The added value of a European Union tuberculosis reference laboratory network--analysis of the national reference laboratory activities.
    Drobniewski FA; Nikolayevskyy V; Hoffner S; Pogoryelova O; Manissero D; Ozin AJ
    Euro Surveill; 2008 Mar; 13(12):. PubMed ID: 18761994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current management of primary mitochondrial disorders in EU countries: the European Reference Networks survey.
    Mancuso M; Lopriore P; Lamperti C; Klopstock T; Rahman S; Licchetta L; Kornblum C; Wortmann SB; Dollfus H; Papadopoulou MT; Arzimanoglou A; Scarpa M; Graessner H; Evangelista T
    J Neurol; 2024 Feb; 271(2):835-840. PubMed ID: 37831128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A European network of email and telephone help lines providing information and support on rare diseases: results from a 1-month activity survey.
    Houyez F; Sanchez de Vega R; Brignol TN; Mazzucato M; Polizzi A
    Interact J Med Res; 2014 May; 3(2):e9. PubMed ID: 24797216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wide disparity of clinical genetics services and EU rare disease research funding across Europe.
    Lynch SA; Borg I
    J Community Genet; 2016 Apr; 7(2):119-26. PubMed ID: 26536881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survey on paediatric tumour boards in Europe: current situation and results from the ExPo-r-Net project.
    Juan Ribelles A; Berlanga P; Schreier G; Nitzlnader M; Brunmair B; Castel V; Essiaf S; Cañete A; Ladenstein R
    Clin Transl Oncol; 2018 Aug; 20(8):1046-1052. PubMed ID: 29313207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Japan as the front-runner of super-aged societies: Perspectives from medicine and medical care in Japan.
    Arai H; Ouchi Y; Toba K; Endo T; Shimokado K; Tsubota K; Matsuo S; Mori H; Yumura W; Yokode M; Rakugi H; Ohshima S
    Geriatr Gerontol Int; 2015 Jun; 15(6):673-87. PubMed ID: 25656311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. JUSTIFICATION OF THE NECESSITY OF INTEGRATED MEDICAL CARE FOR PATIENTS SUFFERING FROM SOCIALLY SIGNIFICANT DISEASES (BASED ON THE RESULTS OF THE TARGET GROUP SURVEY).
    Talalayev K; Kozishkurt O; Golubyatnikov N
    Georgian Med News; 2019; (292-293):32-38. PubMed ID: 31560659
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.